#European cannabis
#European cannabis · page 11
- Companies
From Flowers To Pharma – How Europe Is Forging Its Own Medicinal Cannabis Identity
As Europe embraces medicinal cannabis the continent’s prescribing landscape is developing different characteristics to that of the US.
- News
Danish Cultivator Completes New Facility Gearing Itself For ‘High-Volume Production’
STENOCARE has informed investors that the completion of its pharma-grade cultivation facility is an ‘important milestone’ on its journey towards profitability, despite reporting no sales and increasing losses in its third quarter.
- Opinion
Europe Just Months Away From ‘Recreational Cannabis Domino Effect’, Says Curaleaf Chief
CURALEAF, the US cannabis giant now valued at over $8bn, has officially completed its integration of EMMAC Life Sciences in preparation for what it believes to be the imminent rise of recreational cannabis across Europe.
- Press releases
Akanda Corp Closes $5m Private Placement
Akanda Corp has announced that it has closed a private placement for aggregate gross proceeds of $5,316,000.
- CBD Market
Kanavape Duo Have Their Criminal Convictions Overturned After Seven-Year Legal Battle Which Changed The Way Europe Views CBD
A FRENCH court has today overturned the criminal convictions of the two defendants at the centre of the KanaVape case – seven years after they were first charged.
- Press releases
Akanda’s CanMart Subsidiary To Distribute Award-Winning Cannim Cannabis Products To UK Patients
Akanda Corp has announced that its wholly-owned subsidiary, CanMart has entered into a distribution agreement with Australia-based Cannim to bring the award-winning Lumir range of medical cannabis products to UK patients.
- CBD Market
With Its Stock In Free Fall CBD Firm Chill Brands Looks To Boost ‘Execution’ And ‘Investor Relations’
CHILL Brands Group, a retailer of CBD products in the US, UK and Europe, has seen some £180m wiped off its market value this year.
- News
Irish Clinical Establishment Continues To Shun Cannabis Leaving Medical Access Programme Doomed to Failure
Drug policy specialist Natalie O’Regan on Ireland’s faltering Medical Cannabis Access Programme THE Medical Cannabis Access Programme (MCAP) was launched in 2017, four years later and the first product is now being made available for patients.
- CBD Market
Kanabo Aiming To Become Europe’s First Cannabis ‘Unicorn’
UK Market-listed cannabis business Kanabo is now generating its first revenues following the successful launch of its flagship VapePod product.
- CBD Market
Is CBD A Boom-Or-Bust Fad – Or A Major FMCG Opportunity?
SUGGESTIONS that CBD is a fad – a boom-to-bust market – with the latter imminent, raised a few eyebrows at Cannabis Europa.
- Pharmaceutical
Cannabis Europa – ‘A Melting Pot Of Ideas And Conversations’ – Makes A Successful London Return
STEPHEN Murphy, co-founder and CEO of Prohibition Holdings, kicked-off Cannabis Europa 2021 in central London’s Banking Hall yesterday, welcoming delegates from across Europe and North America, Africa, Asia and Australia.
- Press releases
LYPHE Group Opens Registration To Patient Representative Board
IN an industry first, LYPHE is bringing patients to the table to explore how to improve the patient experience across the organisation – and the wider industry.
